Phoenix Financial’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Phoenix Financial’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,295	Closed	-$267K	–	371
2020 Q2	$267K	Sell	3,295 -3,705	-53%	-$324K	0.01%	267
2020 Q1	$365K	Hold	7,000	–	–	0.02%	257
2019 Q4	$513K	Hold	7,000	–	–	0.02%	170
2019 Q3	$282K	Buy	+7,000	New	+$398K	0.01%	174

Other funds holding PHXM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Phoenix Financial's PHXM Position: Q3 2020 in Review

Phoenix Financial sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2020, closing a stake of 3,295 shares — an estimated $267K sold.

Phoenix Financial first reported a position in PHXM in Q3 2019 and held it in 4 quarters. The position peaked at $513K in Q4 2019. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2020.

Phoenix Financial reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Phoenix Financial sold 3,295 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2020, an estimated $267K.
Phoenix Financial first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2019 and held it in 4 quarters.
Phoenix Financial's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $513K in Q4 2019.
3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2020.

Based on Phoenix Financial's 13F filing for Q3 2020, filed 10 Nov 2020.